查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1140349

互聯給藥設備市場：按類型（注射器、吸入器）、按技術（藍牙、NFC、其他）按最終用戶（家庭護理、醫院）-全球機會分析和行業預測2021-2030

Connected Drug Delivery Devices Market By Type (Injectable, Inhalation Devices), By Technology (Bluetooth, NFC, Others), By End-use (Homecare, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2030
出版日期: | 出版商: Allied Market Research | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

從 2022 年到 2030 年，全球聯網給藥設備市場預計將以 24.29% 的複合年增長率增長，從 2021 年的 2.903 億美元增長到 2030 年的 20.952 億美元。

連接的藥物輸送設備具有集成的功能，包括與各種數字服務的連接。這些設備由各種市場參與者開發，目標是支持卓越的患者監測和諮詢。連接的藥物輸送設備配備了諸如依從性跟蹤器、藥物水平和患者日記等功能，以收集健康信息。這些設備主要用於治療哮喘、慢性阻塞性肺病 (COPD)、糖尿病和其他心血管疾病。

在預測期內，藥物輸送設備在治療過程中的效率和電子醫療設備使用量的增加預計將推動連接藥物輸送設備的市場擴張。除此之外，預計糖尿病、慢性阻塞性肺病和哮喘的患病率增加將為在預測期內增加使用連接的藥物輸送設備提供有利可圖的潛力。

另一方面，與研發能力相關的高成本、有限的基礎設施以及對藥物輸送系統的嚴格監管預計將阻礙市場增長。有利的報銷方案和新興經濟體缺乏技術滲透、低成本替代品的可用性以及中低收入國家缺乏足夠的基礎設施也預計將成為預測期內的市場挑戰。

此外，針對目標研究計劃的公共和私人資金增加、空氣污染水平的上升以及由於全球技術突破導致的產品創新和開發的增加，都將為整個預測期內市場的主要參與者提供有利可圖的機會。未來，隨著戰略聯盟的擴大、互聯網使用量的增加、醫院和實驗室數量的增加、人均醫療費用支出的增加等，預計市場增速將加快。例如，2022 年 2 月，藥物輸送系統的全球領導者 Aptar Pharma 將推出其產品 Hero Tracker Sense，這是一種下一代計量吸入器 (MDI) 附加連接設備，可解決患者吸入技術和依從性問題。 .旨在改善世界各地患有慢性呼吸道疾病（如哮喘、COPD 和囊性纖維化）的患者的生活，了解 MDI 的使用情況並促進更好地遵守規定的治療方法。以及由於 COVID-19。

由於 COVID-19 大流行而導致的全球分銷和銷售渠道中斷可能是連接藥物輸送設備銷量下降的原因。人們不得不面對諸如禁閉、社會排斥等限制。在大流行期間，生產、庫存管理以及商品和服務的分銷等業務流程預計將停止，對全球經濟產生重大影響。然而，冠狀病毒的爆發增加了對用於簡單安全的家庭護理環境的醫療設備的需求。此外，由於需要在線連接設備，醫療保健提供者現在能夠遠程監控患者的藥物治療。這些因素減輕了 COVID-19 大流行的負面影響，並繼續逐步擴大市場。

連接藥物輸送設備市場報告中介紹的領先公司有 Adherium、BD、Proteus Digital Health、proper Health、F. Hoffmann-La Roche Ltd、Ypsomed AG、Cohero Health, Inc、West Pharmaceutical Services、Syncro Technology Corp、Aptar Group Inc 等。

目錄

第 1 章 簡介

第二章執行摘要

第三章市場概況

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
  • 波特五力分析
  • 大公司定位
  • 市場動態
    • 促進者
    • 抑製劑
    • 機會
  • COVID-19 影響分析
  • 監管指南
  • 價值鏈分析
  • 市場份額分析
  • 重點法規分析
  • 專利情況

4 聯網藥物輸送設備市場，按類型

  • 概述
    • 市場規模/預測
  • 注射器
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • 吸入裝置
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類

5 互聯藥物輸送設備市場，按技術

  • 概述
    • 市場規模/預測
  • 藍牙
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：國家分析
  • NFC
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類

6 聯網藥物輸送設備市場，按最終用戶分類

  • 概述
    • 市場規模/預測
  • 家庭護理
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模/預測：按地區
    • 市場分析：按國家分類

第 7 章互聯藥物輸送設備市場：按地區

  • 概述
    • 市場規模/預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按技術
    • 北美市場規模和預測：按最終用戶
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按技術
    • 歐洲市場規模和預測：按最終用戶
    • 歐洲市場規模和預測：按國家分類
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 意大利
      • 歐洲其他地區
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按類型
    • 亞太市場規模和預測：按技術
    • 亞太地區市場規模和最終用戶預測
    • 亞太市場規模和預測：按國家分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 亞太其他地區
  • 拉美亞
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按技術
    • LAMEA 市場規模和預測：按最終用戶
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 阿聯酋
      • 南非共和國
      • 其餘的 LAMEA

第八章 公司情況

  • 介紹
  • 關鍵成功策略
  • 10大公司產品圖
  • 比賽儀表板
  • 競爭熱圖
  • 重大發展

第九章公司簡介

  • Adherium
  • BD
  • Proteus Digital Health
  • PROPELLER HEALTH
  • F. Hoffmann-La Roche Ltd
  • Ypsomed AG
  • Cohero Health, Inc.
  • West Pharmaceutical Services, Inc.
  • Syncro Technology Corp.
  • AptarGroup Inc.
Product Code: A26017

The global connected drug delivery devices market is envisioned to garner $2,095.2 million by 2030, growing from $290.3 million in 2021 at a CAGR of 24.29% from 2022 to 2030.

Connected drug delivery devices are integrated with capabilities that include connectivity to a wide range of digital services. These devices are being developed by various market players with an aim to support superior patient supervision and counselling. Connected drug delivery devices are equipped with several features, such as adherence trackers, dosing remainders, and patient diaries to collect health information. These devices are prominently used in the treatment of asthma, Chronic Obstructive Pulmonary Disease (COPD), diabetes, and other cardiovascular disorders.

The efficiency of drug delivery devices in therapeutic procedures along with rising usage of electronic healthcare devices are anticipated to fuel market expansion for connected drug delivery devices over the forecast period. In addition to this, it is projected that an increase in the prevalence of diabetes, COPD, and asthma will offer a lucrative potential for increasing use of connected drug delivery devices throughout the course of the forecast period.

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, and imposition of stringent regulations on drug delivery systems are expected to hinder the market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period.

Furthermore, increased public-private funding for targeted research initiatives, rising air pollution levels, and an increase in product innovations and development due to global technological breakthroughs will all create lucrative opportunities for key players in the market throughout the projection period. In the future, the market growth rate will be accelerated due to expanding number of strategic alliances, increasing Internet usage, increasing number of hospitals and laboratories, and rising per-capita expenditure on health care spending. For instance, in February 2022, Aptar Pharma, a global leader in drug delivery systems launched a product Hero Tracker Sense, which is a next generation Metered-Dose Inhaler (MDI) add-on connected device, designed to address patient inhalation technique and adherence. It is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory conditions caused by COVID-19, to track their MDI usage and facilitate improved adherence to their prescribed therapy.

Global distribution and sales channel disruption due to COVID-19 pandemic could be blamed for the decline in connected drug delivery devices sales. People had to face restrictions such as lockdown, social distancing, and others. During the pandemic, business processes such as production, inventory management, and distribution of goods and services have ceased, which is expected to have a significant impact on the worldwide economy. However, the coronavirus outbreak made the high demand for simple and secure homecare setting medical devices. A healthcare provider is now able to remotely monitor a patient's medicine due to the requirement for online connectivity equipment. Owing to these factors, the COVID-19 pandemic's negative effects were decreased and the market kept expanding gradually.

The key players profiled in the connected drug delivery devices market report include Adherium, BD, Proteus Digital Health, propeller Health, F. Hoffmann-La Roche Ltd, Ypsomed AG, Cohero Health, Inc., West Pharmaceutical Services, Syncro Technology Corp., and AptarGroup Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the connected drug delivery devices market analysis from 2021 to 2030 to identify the prevailing connected drug delivery devices market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the connected drug delivery devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global connected drug delivery devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Injectable Devices
  • Inhalation Devices
  • Others

By Technology

  • NFC
  • Bluetooth
  • Others
  •  By End-user
  • Homecare settings
  • Hospitals

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • United Arab Emirates
  • South Africa
  • Rest of LAMEA
  • List of Key Players Profiled in the Report
  • Adherium
  • BD
  • Proteus Digital Health
  • propeller Health
  • F. Hoffmann-La Roche Ltd
  • Ypsomed AG
  • Cohero Health, Inc.
  • West Pharmaceutical Services, Inc.
  • Syncro Technology Corp. 
  • AptarGroup Inc.
  • Key Market Segments

By Type

  • Injectable
  • Inhalation Devices

By Technology

  • Bluetooth
  • NFC
  • Others

By End-use

  • Homecare
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Adherium
    • BD
    • Proteus Digital Health
    • PROPELLER HEALTH
    • F. Hoffmann-La Roche Ltd
    • Ypsomed AG
    • Cohero Health, Inc.
    • West Pharmaceutical Services, Inc.
    • Syncro Technology Corp.
    • AptarGroup Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Regulatory Guidelines
  • 3.8.Value Chain Analysis
  • 3.9.Market Share Analysis
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Injectable
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Inhalation Devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Bluetooth
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 NFC
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Homecare
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Hospitals
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Technology
    • 7.2.4 North America Market size and forecast, by End-use
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Technology
      • 7.2.5.1.3 Market size and forecast, by End-use
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Technology
      • 7.2.5.2.3 Market size and forecast, by End-use
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Technology
      • 7.2.5.3.3 Market size and forecast, by End-use
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Technology
    • 7.3.4 Europe Market size and forecast, by End-use
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Technology
      • 7.3.5.1.3 Market size and forecast, by End-use
      • 7.3.5.2 United Kingdom
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Technology
      • 7.3.5.2.3 Market size and forecast, by End-use
      • 7.3.5.3 France
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Technology
      • 7.3.5.3.3 Market size and forecast, by End-use
      • 7.3.5.4 Spain
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Technology
      • 7.3.5.4.3 Market size and forecast, by End-use
      • 7.3.5.5 Italy
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Technology
      • 7.3.5.5.3 Market size and forecast, by End-use
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Technology
      • 7.3.5.6.3 Market size and forecast, by End-use
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Technology
    • 7.4.4 Asia-Pacific Market size and forecast, by End-use
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Technology
      • 7.4.5.1.3 Market size and forecast, by End-use
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Technology
      • 7.4.5.2.3 Market size and forecast, by End-use
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Technology
      • 7.4.5.3.3 Market size and forecast, by End-use
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Technology
      • 7.4.5.4.3 Market size and forecast, by End-use
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Technology
      • 7.4.5.5.3 Market size and forecast, by End-use
      • 7.4.5.6 Rest Of Asia Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Technology
      • 7.4.5.6.3 Market size and forecast, by End-use
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Technology
    • 7.5.4 LAMEA Market size and forecast, by End-use
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Technology
      • 7.5.5.1.3 Market size and forecast, by End-use
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Technology
      • 7.5.5.2.3 Market size and forecast, by End-use
      • 7.5.5.3 UAE
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Technology
      • 7.5.5.3.3 Market size and forecast, by End-use
      • 7.5.5.4 South Africa
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Technology
      • 7.5.5.4.3 Market size and forecast, by End-use
      • 7.5.5.5 Rest of LAMEA
      • 7.5.5.5.1 Market size and forecast, by Type
      • 7.5.5.5.2 Market size and forecast, by Technology
      • 7.5.5.5.3 Market size and forecast, by End-use

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Adherium
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 BD
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Proteus Digital Health
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 PROPELLER HEALTH
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 F. Hoffmann-La Roche Ltd
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Ypsomed AG
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Cohero Health, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 West Pharmaceutical Services, Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Syncro Technology Corp.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 AptarGroup Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INJECTABLE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 3. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INJECTABLE, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 4. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INHALATION DEVICES, BY REGION, 2021-2030 ($MILLION)
  • TABLE 5. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INHALATION DEVICES, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 7. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR BLUETOOTH, BY REGION, 2021-2030 ($MILLION)
  • TABLE 8. CONNECTED DRUG DELIVERY DEVICES MARKET FOR BLUETOOTH, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 9. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR NFC, BY REGION, 2021-2030 ($MILLION)
  • TABLE 10. CONNECTED DRUG DELIVERY DEVICES MARKET FOR NFC, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 11. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 12. CONNECTED DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 14. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOMECARE, BY REGION, 2021-2030 ($MILLION)
  • TABLE 15. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOMECARE, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 16. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2030 ($MILLION)
  • TABLE 17. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 18. CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION, 2021-2030 ($MILLION)
  • TABLE 19. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 20. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 21. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 22. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 23. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 24. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 25. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 26. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 27. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 28. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 29. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 30. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 31. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 32. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 33. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 34. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 35. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 36. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 37. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 38. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 39. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 40. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 41. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 42. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 43. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 44. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 45. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 46. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 47. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 48. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 49. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 50. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 51. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 52. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 53. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 54. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 55. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 56. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 57. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 58. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 59. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 60. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 61. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 62. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 63. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 64. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 65. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 66. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 67. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 68. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 69. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 71. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 72. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 73. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 74. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 75. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 76. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 77. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 78. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 79. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
  • TABLE 80. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 81. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 82. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 83. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 84. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 85. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 86. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 87. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 88. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 89. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 90. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 91. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 92. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
  • TABLE 93. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
  • TABLE 94. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
  • TABLE 95.ADHERIUM: COMPANY SNAPSHOT
  • TABLE 96.ADHERIUM: OPERATING SEGMENTS
  • TABLE 97.ADHERIUM: PRODUCT PORTFOLIO
  • TABLE 98.ADHERIUM: NET SALES,
  • TABLE 99.ADHERIUM: KEY STRATERGIES
  • TABLE 100.BD: COMPANY SNAPSHOT
  • TABLE 101.BD: OPERATING SEGMENTS
  • TABLE 102.BD: PRODUCT PORTFOLIO
  • TABLE 103.BD: NET SALES,
  • TABLE 104.BD: KEY STRATERGIES
  • TABLE 105.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
  • TABLE 106.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
  • TABLE 107.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 108.PROTEUS DIGITAL HEALTH: NET SALES,
  • TABLE 109.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
  • TABLE 110.PROPELLER HEALTH: COMPANY SNAPSHOT
  • TABLE 111.PROPELLER HEALTH: OPERATING SEGMENTS
  • TABLE 112.PROPELLER HEALTH: PRODUCT PORTFOLIO
  • TABLE 113.PROPELLER HEALTH: NET SALES,
  • TABLE 114.PROPELLER HEALTH: KEY STRATERGIES
  • TABLE 115.F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 116.F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 117.F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 118.F. HOFFMANN-LA ROCHE LTD: NET SALES,
  • TABLE 119.F. HOFFMANN-LA ROCHE LTD: KEY STRATERGIES
  • TABLE 120.YPSOMED AG: COMPANY SNAPSHOT
  • TABLE 121.YPSOMED AG: OPERATING SEGMENTS
  • TABLE 122.YPSOMED AG: PRODUCT PORTFOLIO
  • TABLE 123.YPSOMED AG: NET SALES,
  • TABLE 124.YPSOMED AG: KEY STRATERGIES
  • TABLE 125.COHERO HEALTH, INC.: COMPANY SNAPSHOT
  • TABLE 126.COHERO HEALTH, INC.: OPERATING SEGMENTS
  • TABLE 127.COHERO HEALTH, INC.: PRODUCT PORTFOLIO
  • TABLE 128.COHERO HEALTH, INC.: NET SALES,
  • TABLE 129.COHERO HEALTH, INC.: KEY STRATERGIES
  • TABLE 130.WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
  • TABLE 131.WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
  • TABLE 132.WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
  • TABLE 133.WEST PHARMACEUTICAL SERVICES, INC.: NET SALES,
  • TABLE 134.WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATERGIES
  • TABLE 135.SYNCRO TECHNOLOGY CORP.: COMPANY SNAPSHOT
  • TABLE 136.SYNCRO TECHNOLOGY CORP.: OPERATING SEGMENTS
  • TABLE 137.SYNCRO TECHNOLOGY CORP.: PRODUCT PORTFOLIO
  • TABLE 138.SYNCRO TECHNOLOGY CORP.: NET SALES,
  • TABLE 139.SYNCRO TECHNOLOGY CORP.: KEY STRATERGIES
  • TABLE 140.APTARGROUP INC.: COMPANY SNAPSHOT
  • TABLE 141.APTARGROUP INC.: OPERATING SEGMENTS
  • TABLE 142.APTARGROUP INC.: PRODUCT PORTFOLIO
  • TABLE 143.APTARGROUP INC.: NET SALES,
  • TABLE 144.APTARGROUP INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION
  • FIGURE 2.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
  • FIGURE 3.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CONNECTED DRUG DELIVERY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.REGULATORY GUIDELINES
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.MARKET SHARE ANALYSIS
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TYPE,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INJECTABLE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF INHALATION DEVICES CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 21.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TECHNOLOGY,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BLUETOOTH CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF NFC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 25.CONNECTED DRUG DELIVERY DEVICES MARKET,BY END-USE,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOMECARE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
  • FIGURE 28.CONNECTED DRUG DELIVERY DEVICES MARKET BY REGION,2021
  • FIGURE 29.U.S. CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 30.CANADA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 31.MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 32.GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 33.UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 34.FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 35.SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 36.ITALY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 37.REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 38.CHINA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 39.JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 40.INDIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 41.SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 42.AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 43.REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 44.BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 45.SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 46.UAE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 47.SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 48.REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
  • FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 53.COMPETITIVE DASHBOARD
  • FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 55.ADHERIUM.: NET SALES ,($MILLION)
  • FIGURE 56.BD.: NET SALES ,($MILLION)
  • FIGURE 57.PROTEUS DIGITAL HEALTH.: NET SALES ,($MILLION)
  • FIGURE 58.PROPELLER HEALTH.: NET SALES ,($MILLION)
  • FIGURE 59.F. HOFFMANN-LA ROCHE LTD.: NET SALES ,($MILLION)
  • FIGURE 60.YPSOMED AG.: NET SALES ,($MILLION)
  • FIGURE 61.COHERO HEALTH, INC..: NET SALES ,($MILLION)
  • FIGURE 62.WEST PHARMACEUTICAL SERVICES, INC..: NET SALES ,($MILLION)
  • FIGURE 63.SYNCRO TECHNOLOGY CORP..: NET SALES ,($MILLION)
  • FIGURE 64.APTARGROUP INC..: NET SALES ,($MILLION)